TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06727201

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron (Zofran)
Description: Ondansetron will be given intravenously in a dose of 0.1mg/kg 10 minutes before spinal anaesthesia as single shot.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline (NaCl 0,9 %) (placebo)
Description: normal saline infusion will be given intravenously 10 minutes before spinal anaesthesia
Study: NCT06726772

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Psychotherapy
Description: Group psychotherapy based on Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) elements
Study: NCT06726304

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baby Carrier Intervention
Description: Mothers in the intervention group will have the opportunity to choose between two different soft ergonomic baby carriers and will receive instructions on how to use the carrier of their choice. Infants will be placed chest-to-chest in the carrier, supported by the mother's upper torso for a prescribed amount of time during the period of six weeks.
Study: NCT06727149

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No intervention was performed to reduce pain, fear and anxiety in the control group

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Group
Description: The children in the VR group were informed about the virtual reality glasses and told that they could remove the glasses at any time if they felt uncomfortable during the procedure
Study: NCT06726798

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal dissection with EndoRobotics traction device
Description: All patients received robotic ESD under general anesthesia or monitored anaesthetic care at the endoscopy center of Prince of Wales Hospital. The targeted lesion would first be localized and pre-injected using a mixture of normal saline, indigocarmine, epinephrine and sodium hyaluronate. The robotic endoscopic traction device was then inserted to reach the target. Mucosal incision first started from the anal side followed by lifting with the grasper\[Figure 1; Video 1\]. Vio 3 diathermy system (ERBE, Germany) was used with endocut Q effect 3 and forced coagulation effect 3. Further submucosal dissection would be performed by electrocautery knife with traction achieved via EndoRobotics traction. Upon completion, the specimen would be retrieved upon withdrawal of the whole system.
Study: NCT06725433

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nissen fundoplication
Description: Hiatal hernia repair and Nissen fundoplication

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dor fundoplication
Description: Hiatal hernia repair and Dor fundoplication
Study: NCT06725303

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excimer
Description: Light energy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Excimer
Description: Light energy
Study: NCT06727461

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based Feeding EnhancEment in Dementia (Feed@home)
Description: The FEED@home program is an 8-week initiative led by a speech therapist (ST) and nurse team through teleconsultations and home visits:~* Within 3 days after discharge, a nurse teleconsultation with the family caregiver to assess the patient's mealtime behaviors and provide feeding strategy recommendations and educational materials.~* Two to three home visits by STs during mealtime (depending on the mastery of feeding techniques) to assess swallowing and cognitive feeding issues, providing tailored interventions and proper training of feeding techniques.~* Two teleconsultations by nurses to assess the caregiver's techniques and provide additional training.~* One additional home visit during mealtime by a nurse to assess the caregiver's mastery of the feeding techniques through observation.~* The program lasts 8 weeks, regardless of readmissions, unless the patient converts to tube feeding, moves to a care home, passes away, or withdraws from study.
Study: NCT06726707

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diaper with a copper-based product
Description: The device is an incontinence aid and its performance is related to its ability to absorb and contain urine/ feces as well as keeping the skin dry.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Barrier product with common diaper
Description: The control device (common diaper) is an incontinence aid and its performance is related to its ability to absorb and contain urine/ feces as well as keeping the skin dry.
Study: NCT06213155

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoneurolysis
Description: Cryoneurolysis

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Stimulation
Description: Stimulation
Study: NCT05844020

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational materials
Description: Trauma-informed intimate partner violence screening, brief interventions, and referrals to treatment by providers
Study: NCT05958849

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sovalteinib Solutumab Tegeo
Description: Soventinib in combination with solutumab and tegeo for advanced pancreatic cancer
Study: NCT05326646

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Description: After the realisation of a wireless motility capsule, patients will underwent 6 weeks of low FODMAP diet after dietician education. Symptomatic scores (IBS-SSS, GIQLI, HAD) and stools samples (metabolomic and lipidomic) will be performed before and after the low FODMAP diet.
Study: NCT04730856

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tinzaparin
Description: day subcutaneously • Follow-up phase 1 (Day 15 to day 30): The information is obtained at discharge and on day +14, + 28 on 30 days. The latter information is obtained from patients, from medical records or by telephone contact at the patient's home.~• Follow-up phase 2 (At 3 months: Information is obtained from patients, medical records, or by telephone contact at the patient's home.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tinzaparin
Description: day subcutaneously • Follow-up phase 1 (Day 15 to day 30): The information is obtained at discharge and on day +14, + 28 on 30 days. The latter information is obtained from patients, from medical records or by telephone contact at the patient's home.~• Follow-up phase 2 (At 3 months: Information is obtained from patients, medical records, or by telephone contact at the patient's home.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tinzaparin
Description: day subcutaneously • Follow-up phase 1 (Day 15 to day 30): The information is obtained at discharge and on day +14, + 28 on 30 days. The latter information is obtained from patients, from medical records or by telephone contact at the patient's home.~• Follow-up phase 2 (At 3 months: Information is obtained from patients, medical records, or by telephone contact at the patient's home.
Study: NCT06280508

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab, Apatinib, Gemcitabine, cisplatin
Description: Chemotherapy combined with Adebrelimab and Apatinib neoadjuvant therapy for 3 cycles before surgery, and Adebrelimab combined with Apatinib adjuvant therapy for 6 months after surgery
Study: NCT05999266

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasonographic Measurements
Description: In patients with or without knee pain, the cartilage thickness measurement of the knee joint will be measured from 3 points by ultrasound. At the same time, Quadriceps and Hamstring muscle thickness measurements of the patients will be made from the midpoints where the muscle thickness is the highest.

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasonographic Measurements
Description: In patients with or without knee pain, the cartilage thickness measurement of the knee joint will be measured from 3 points by ultrasound. At the same time, Quadriceps and Hamstring muscle thickness measurements of the patients will be made from the midpoints where the muscle thickness is the highest.
Study: NCT06420271

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real (real iTBS/tACS + exergaming)
Description: Stimulation will be applied to the cerebellum. The tACS session duration will be 190 seconds with a frequency of 5 Hz coupled with iTBS (coil positioned tangentially with respect to the scalp)(600 pulses consisting of bursts of 3 stimuli at 50 Hz, repeated at intervals of 200ms, with an intensity of 80% of active motor threshold -AMT-) (Huang et al., 2005) for a total duration of 190 seconds. The exergaming will be performed with an adaptive system, comprising a force platform connected to a computer. The system is designed to enhance standard balance rehabilitation programs by guiding the user's performance of prescribed physical exercises through a video interface. Patients will perform 3 different exercises (10 minutes of training for a total of 30 minutes): 1) latero-lateral load shift; 2) antero posterior load shift; 3) omnidirectional displacement (combined latero-lateral and antero-posterior loading).

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham (sham iTBS/tACS + exergaming)
Description: Stimulation will be applied to the cerebellum. The tACS session duration will be 10 seconds with a frequency of 5 Hz coupled with sham iTBS (coil positioned perpendicularly with respect to the scalp)(600 pulses consisting of bursts of 3 stimuli at 50 Hz, repeated at intervals of 200ms, with an intensity of 80% of active motor threshold -AMT-) (Huang et al., 2005) for a total duration of 190 seconds. The exergaming will be performed with an adaptive system, comprising a force platform connected to a computer. The system is designed to enhance standard balance rehabilitation programs by guiding the user's performance of prescribed physical exercises through a video interface. Patients will perform 3 different exercises (10 minutes of training for a total of 30 minutes): 1) latero-lateral load shift; 2) antero posterior load shift; 3) omnidirectional displacement (combined latero-lateral and antero-posterior loading).
Study: NCT05967650

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: standard hepatitis B vaccine
Description: IBD patients with negative HBV will be diveded in to two arms first arm vaccinated with standard HBV vaccine regemin( dose 0.2.6)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: accelerated HBV Vaccine
Description: IBD patients with negative HBV will be diveded in to two arms second arm vaccinated with accelerated HBV vaccine regemin( dose 1.2.3)
Study: NCT06357039

Intervention type: DEVICE
Intervention: Sleep tracking device
Description: In addition to polysomnography, a device containing EEG+PPG sensors for sleep classification was placed on the forehead, and another device containing PPG and accelerometer sensors was placed on the wrist. The wrist to which the device is attached is randomly assigned.

Intervention type: DEVICE
Intervention: Sleep tracking device
Description: In addition to polysomnography, a device containing EEG+PPG sensors for sleep classification was placed on the forehead, and another device containing PPG and accelerometer sensors was placed on the wrist. The wrist to which the device is attached is randomly assigned.
Study: NCT01464515

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: H-Coil Deep TMS
Description: this group will receive high frequency treatment of deep TMS with 10Hz

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM Coil TMS
Description: this group will receive SHAM treatment of deep TMS
Study: NCT06014073

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
Description: Phase 1 dose escalation (3+3) : dose 1 (1 × 10\^6 cells/kg) , dose 2 (3 × 10\^6 cells/kg), dose 3 (1 × 10\^7 cells/kg); Phase 2 : dose of RP2D.~No more than 2 × 10\^5 per kilogram of allogenic residual CD3+T cells harbouring in grafts can only be released for recipient infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Intravenous fludarabine 30\~50 mg/m\^2/day on days -5, -4, and -3.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 500\~1000 mg/m\^2/day on days -5, -4, and -3.
Study: NCT05994716

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Description: A) Monthly completion data on the web platform: 1) SCCAI for Ulcerative colitis and Harvey-Bradshaw index for Crohn disease. 2) IBD disk questionnaire to evaluate disease dynamics. 3) General blood test.~B) Possibility of online consultation with a gastroenterologist upon request via chat or phone call.~C) Access to educational information about IBD, necessary lifestyle changes, dietary recommendations;~D) monthly phone call will be made to each patient from the intervention group to answer any questions or concerns they may have and to interview them according to the checklist.
Study: NCT04966702

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin Pill
Description: Using a MDA approach, fieldworkers will administer ivermectin using directly observed treatment methodology to participants

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin Pill
Description: Using a MDA approach, fieldworkers will administer ivermectin using directly observed treatment methodology to participants

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin Injectable Product
Description: Veterinary ivermectin injectable will be given to livestock in the relevant cluster
Study: NCT06649916

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parentese Speech
Description: Novel words are introduced in parentese, a type of speech that is typically characterized by greater pitch variation, longer duration, and louder volume

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Adult Registered Speech
Description: Novel words are introduced in standard adult register.
Study: NCT06653543

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan mobilization with arm movement
Description: mulligan mobilization applied on cervical spine with arm movement

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: conventional therapy of cevical radiculopathy
Description: hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional therapy of cevical radiculopathy
Description: hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition
Study: NCT05612581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIR-2218
Description: VIR-2218 given by subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: TDF given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG-IFNα
Description: PEG-IFNα given by subcutaneous injection
Study: NCT04680169

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bronchoscopic intubation through AuraGain LMA
Description: Comparing two different SGAs as conduit for bronchoscopic tracheal intubation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bronchoscopic intubation through I-gel SGA
Description: Comparing two different SGAs as conduit for bronchoscopic tracheal intubation
Study: NCT05438745

Intervention type: OTHER
Intervention: Copenhagen Burnout Inventry
Description: Questionnaire
Study: NCT05811611

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WeChat Mini Program plus tailored online health promotion videos
Description: Participants have access to a WeChat Mini Program. Participants will also watch online health promotion videos tailored to their current sexual behaviors.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WeChat Mini Program Only
Description: Participants only have access to a WeChat Mini Program.
Study: NCT01423448

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bulletin board
Description: An asynchronous online bulletin board for people with experience of depression
Study: NCT05885334

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: Caregivers will not receive any educational solution different than what is done by routine in centers. After six months, performance in caregivers tasks will be video recorded.
Study: NCT05256238

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: comprehensive supervised exercise program (CSEP)
Description: The CSEP starts as soon as possible after cancer diagnosis and lasts for 12 weeks:~* week 1-6 (during cancer treatment): 2 supervised sessions at the exercise room of the University Hospital Leuven in connection to the radiotherapy treatment session and one additional session at home. Patients will receive equipment to perform the program at home, e.g. weights, therabands,...~* week 7-12 (after cancer treatment): 1 supervised session at the exercise room of University Hospital Leuven in connection to the follow-up consultations (once a week) with the oncologist and two additional sessions at home~* maintenance program (from week 13), patients will exercise at home with a monthly teleconsultation
Study: NCT06332521

Intervention type: OTHER
Intervention: Acoustic signal analysis method
Description: Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.

Intervention type: OTHER
Intervention: Acoustic signal analysis method
Description: Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.
Study: NCT06551532

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent program
Description: Lumbopelvic training (foam rolling, manual therapy, mobility, posture, and strength training) and sprint technique program.
Study: NCT06100523

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visioconsulation
Description: Meeting by videoconsultation with professionals adapted to the exposures highlighted by the questionnaires for patients who responded on the dedicated application (Arm A)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: self-assessment questionnaire
Description: self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hair sampling
Description: hair sampling from the 2 members of the couple

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: hair sampling
Description: hair sampling from the 2 members of the couple

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-assessment questionnaire on dedicated application
Description: self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Specialized follow-up
Description: proactive healthcare pathway : active support of corrective measures implemented with couples by the platform, with the help of the application

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-assessment questionnaire for follow-up
Description: self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: self-assessment questionnaire for follow-up
Description: self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course
Study: NCT04010851

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer co-led educational group
Description: The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Comparator treatment as usual
Description: Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise. These interventions include: medication, psychotherapy, or a combination of these two approaches.
Study: NCT05885334

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Caregivers will receive a educational solution of virtual reality videos with care situations simulations for 1h. After six months, performance in caregivers tasks will be video recorded.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented reality
Description: Caregivers will receive a educational solution of augmented reality videos with care situations simulations for 1h. After six months, performance in caregivers tasks will be video recorded.
Study: NCT06139822

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: Hamstring stretching is the main intervention which is being used along with convention protocol for plantar fasciitis.